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Abstract
Objectives: To evaluate the epidemiological aspects of adenoid cystic carcinoma (ACC) and to evaluate the differ-
ent therapeutic possibilities as well as the percentage of survival.
Study Design: A retrospective, meta-analytic, observational study was carried out by selecting a total of 13 ar-
ticles, which provided a sample size of 263 cases of patients who had been diagnosed with ACC in the minor 
salivary glands.
Results: ACC was found to be more common among women (56.5%) and the average age at diagnosis was 55.26 
years old. The primary location of the tumor was in the palate in 57% of the cases, the predominant pattern being 
cribiform. The treatment of choice was therapy combined with surgery and radiotherapy in 62.7% of the subjects. 
The overall survival rate was 70.76% and 56.76%, at 5 and 10 years respectively. 
Conclusions: Early detection of adenoid cystic carcinoma is necessary in order to enable making an earlier prog-
nosis and thus enable a better quality of life for the patient.
Key words: Adenoid cystic carcinoma, minor salivary glands, chemotherapy and radiotherapy of the head and 
neck.
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Introduction
Adenoid cystic carcinoma (ACC) was first described 
by Billroth in 1859, using the term “cylindroma”, called 
such because it forms a cross between connective and 
epithelial elements which make formations that are sim-
ilar in appearance to cylindromatosis.
This tumor is characterized as presenting a prolonged 
clinical course, with a slow and progressive growth and 
a tendency to recur locally as well as metastasize re-
gionally and systemically, sometimes at very late stag-
es.  In addition, it presents a strong neurotropism, which 
is a major route of tumor dissemination. (1)
As far as the prevalence of ACC, it represents a quarter 
of malignant tumors of the salivary glands, both in the 
major and in the minor salivary glands, although more 
frequently located in the minor salivary glands, mainly 
at the roof of the mouth, which accounts for 31% of the 
lesions. (2)
ACC usually appears between the third and ninth dec-
ade of life, with a peak incidence in patients between 
the ages of 40 and 70 years old; however, it does not 
appear to be predominant in any sex. 
As for its histopathology, ACC are distinguished by 
three different patterns: tubular, cribiform and solid. 
Contrary to what its name might imply, there are no 
cystic cavities or mucous, mucinous or gelatinous ar-
eas, although macroscopically, there is a mass with a 
hard consistency, well circumscribed and with a wide 
base of implantation, usually very attached to adjacent 
structures while maintaining the integrity of the mu-
cosal surface up to advanced stages.
For the extension diagnosis, computerized tomography 
(CT) and magnetic resonance (MR) will be the methods 
of choice, whereas fine-needle aspiration (FNA) or bi-
opsy of the minor salivary glands along with immuno-
histochemical markers such as the antigen Ki-67 will be 
used for the histological diagnosis. As for the differen-
tial diagnosis, this must include benign and malignant 
tumors such as pleomorphic adenoma, polymorphic ad-
enocarcinoma, basaloid carcinoma, or mucoepidermoid 
carcinoma.
For treatment of this tumor, there is not a single thera-
peutic method that satisfies all needs, which is why an 
individual planning of the treatment must be made based 
on the clinical and histological diagnosis, in order to ob-
tain the highest possibilities of healing, local control and 
reduction of the symptoms, keeping in mind that it is a 
very invasive and clinically unpredictable tumor.  
The treatment must be carried out by different profes-
sionals, which makes it a multidisciplinary and mul-
tiphasic treatment that includes the following types: 
surgical therapy, radiotherapy, chemotherapy and com-
bined therapy (surgery and radiotherapy, radiotherapy 
and chemotherapy), the latter being the treatment of 
choice. (3)
Thus, the objectives presented in this study were to 
evaluate the epidemiological aspects of ACC, such as 
the age of the patient when diagnosed, the sex of the 
patient, the primary location of the tumor, and evaluate 
the different therapeutic possibilities as well as the per-
centages of patients who survive this tumor. 
Material and Method
A retrospective, meta-analytic, observational study was 
carried out on the results obtained through a biblio-
graphic search in PubMed. The keywords used were: 
“adenoid cystic carcinoma”, “minor salivary gland”, 
“head and neck radiotherapy” and “chemotherapy”.
A total of 35 articles ranging between the period from 
1997 to 2009 were reviewed, which had to fulfill the 
following established inclusion criteria:
.  Articles that present at least one clinically diagnosed 
case of ACC
.  Articles that contain patients diagnosed with ACC, 
whose primary location is in the minor salivary glands
.  Articles that evaluate the treatment used as well as the 
survival of the patients
Once the aforementioned inclusion criteria were applied, a 
total of 13 articles were selected, which provided a sample 
size of 263 cases.  (Table 1) These cases were treated by 
making a descriptive statistical analysis, evaluating the dif-
ferent variables using tables and graphs of frequency and 
proportions. The following parameters were evaluated: 
1. Age: The age of the subjects was recorded at the time 
of diagnosis, analyzing both their mean age as well as 
the age range within which they fell. 
2. Sex: The patient’s sex was established in the percent-
age and in the ratio, and we evaluated whether there was 
any correlation between the appearance of the pathol-
ogy and the patient’s age.
3. Primary location: The different locations where the 
primary tumor could appear and also the frequency of 
appearance of each one of them was evaluated.
4. Histological pattern: The subjects were classified 
using category variables, according to the histological 
type, dividing it into cribiform, tubular and solid; the 
frequency of appearance was evaluated and correlated 
with the prognosis.
5. Margins: The existence or non-existence of surgical 
margins affected was recorded and their possible rela-
tionship with the prognosis was evaluated.
6. Treatment: The therapeutic approaches used in the 
different patients were analyzed, classifying them into 
the following categories: 
.  Surgical treatment
.  Surgical treatment combined with radiotherapy
. Surgical treatment combined with radiotherapy and 
chemotherapy
.  Radiotherapy
.  Chemotherapy
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7. Metastasis: The appearance of local and distant me-
tastasis, or the lack thereof following the treatment, 
was recorded and correlated with the survival of the 
patients. 
8. Survival: The percentage of survival of the patients 
was analyzed at 5 and 10 years in order to evaluate the 
prognosis of this type of pathology. 
Results
The population studied was variable according to each 
parameter indicated, as it was not possible to obtain all 
of the data for each one of the individuals, arriving at 
the following results: 
With respect to the age variable, the 152 patients evalu-
ated at the time of the diagnosis were between the ages 
of 15 and 87 years old, with a range of 55 years old, the 
mean age being 55.26 years old.
As far as the patient’s sex, in the 184 patients studied, 
ACC occurs more frequently in women, who account 
for 104 of the cases and represent 56.5% of the patients, 
compared to the 43.5% or 80 cases which affected men. 
The proportion between women and men was 1.3 more 
women than men. 
As for the primary location of the ACC in a total of 193 
subjects, the most common area was the palate, account-
ing for 57% of the cases, corresponding to 110 patients; 
followed by the tongue, with 31 cases (16%); in the oral 
mucosa, with 28 cases (14.5%); in fourth position was 
the floor of the mouth, with 16 cases (8.3%); and lastly, 
the mandible and lip (Fig. 1).
With respect to the histology, we were able to evaluate 
112 cases, the most frequent histological pattern being 
cribiform, corresponding to 52 patients (46.4%); fol-
lowed by the solid pattern, present in 36.6% of the pa-
tients; and a tubular patter in less proportion, account-
ing for only 17% of the cases.
On the other hand, the therapy in these patients included 
different types of treatment, the most common being 
surgical therapy combined with radiotherapy in 62.7% 
of the cases, followed by surgical treatment in 34.6% 
AUTHOR/YEAR No. of CASES
HISTOLOGICAL
PATTERN TREATMENT MARGINS METASTASIS
Cheuk et al. 1999 (4) 3 2 Cribiform 1 Solid Qx +Rt: 3 
Positive: 2 
Negative: 1 
2 Distant  
2 Local 
Avery et al. 2000 (5) 9 - Qx + Rt: 9 Positive: 2 Negative: 7 0
Hashimoto et al. 2002 
(6) 4
3 Cribiform 
1 Tubular 
Qx+ Rt +K: 2 
Qx+ Rt:1 
K:1
-
   1  Distant 
Kokemueller et al.    
2004 (7) 
44 - Qx + Rt : 8 Qx: 36 
Positive: 17 
Negative: 
27
11 Distant 
16 Local 
Carrasco et al.  
2006 (8) 1 Cribiform Qx + Rt Negative Local 
Triantafillidou et al. 
2006 (9) 22 - Qx +Rt:22 - 
2 Distant 
2 Local 
Al-Sukhum et al. 
2006 (10) 1 Cribiform Qx Negative 0 
Soares et al.  
2008 (11) 1 Cribiform Qx + Rt - 0 
Copelli et al. 
 2008 (12) 26
7 Cribiform 
13 Solid 
6 Tubular 
Qx + Rt: 26 
Positive: 9 
Negative: 
17
4 Distant 
3 Local 
García-de Marcos et 
al. 2008 (13) 1 Tubular Qx + Rt Positive 0 
Bianchi et al. 
 2008 (14) 67
31 Cribiform 
26 Solid 
10 Tubular 
Qx + Rt: 40 
Qx:27
Positive: 45 
Negative: 
22
20 Distant 
15 Local 
Agarwal et al. 
 2008 (15) 76 - 
Qx: 23 
Rt :2 
Qx + Rt: 51 
- 6 Distant 
Luna-Ortiz et al. 
2009 (16) 8
         6 Cribiform 
1 Solid 
1 Tubular 
No: 1 
Qx: 4 
Qx + Rt: 2 
Qx +Rt+ K:1 
Positive: 1 
Negative: 6 
3 Distant 
8 Local 
Table 1. Histological pattern, treatment, surgical margins and metastasis. 
Qx: Surgery; Rt: Radiotherapy; K: Chemotherapy; No: Untreated.
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of the cases, surgical treatment associated with chemo-
therapy and radiotherapy in 1.1% of the cases, only ra-
diotherapy in 0.8% of the cases, and only chemotherapy 
with very small, almost insignificant percentages, or no 
treatment in 0.4% cases, corresponding to 2 patients re-
spectively.
As for the state of the surgical margins at the micro-
scopic level, there were 159 patients to be analyzed, 82 
of which presented margins free of tumors, which rep-
resented 51.57% of the cases, compared to 77 patients 
whose margins were affected.
Metastasis was evaluated in all of the patients, finding 
a total of 96 metastases, 48.96% of which were at the 
local level, whereas 51.04% were distant metastases. 
With respect to the topographic location of the 49 dis-
tant metastases, 33 were located in the lungs, 13 in the 
lungs and bone, 3 in the brain and only one in the bone 
(Fig. 2).
The overall survival of our series was analyzed in dif-
ferent stages as well as in different numbers of individu-
als. Thus, in the 259 patients evaluated, the survival rate 
at 5 years was 70.76%, whereas at 10 years, and having 
analyzed a total of 183 subjects, the percentage drops 
to 56.76%. 
Discussion
At present, adenoid cystic carcinoma (ACC) accounts 
for approximately 29.6% of tumors of the minor salivary 
glands. It is characterized as presenting a prolonged 
clinical course, with a slow and progressive growth, and 
a tendency towards perineural invasion and dissemina-
tion through the adjacent nerves and tissues.
With respect to the age of the patient when diagnosed 
with adenoid cystic carcinoma, authors such as Yih et 
al. (17) find results similar to our study, establishing a 
mean age of 58.6 years old. In this sense, authors such as 
Kokemueller et al. (7) establish a very wide age range, 
between 15 and 82 years old, whereas others such as 
Fig. 1. Primary location of the tumor.
331
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3
Lungs
Bone
Lungsandbone
Brain
Fig. 2. Location of distant metastases.
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Hashimoto et al. (6) place the age range between 46 and 
64 years old, the latter results being closer to our mean 
age obtained.
As for the patient’s sex, there is a certain predisposition 
towards females, given that 56.6% of the patients were 
women, compared to 43.5% who were men. However, 
there are other studies, such as those conducted by da 
Cruz et al. (18), which challenge the previous results 
and in which there is predominance among males. 
If we evaluate the topographic location of the ACC, au-
thors such as Toida et al. (19) affirm in their study of 10 
patients that the most common location is in the palate, 
representing 70% of the cases, followed by the oral mu-
cosa, a finding that coincides with the study conducted 
by Dhanutai et al. (20) and with that obtained in our se-
ries, in which the palate was the predominant location.
Some authors such as Sequeiros et al. (21) find influ-
ence of the histological subtype in the prognosis of the 
illness, considering the tubular and cribiform patterns 
to be those with the best prognosis, unlike the solid sub-
type, which presents a high rate of malignancy and less 
rate of survival. Thus, the most common histological 
pattern in our case was cribiform, representing 46.4% 
of the cases, followed by the solid and the tubular pat-
tern, with 36.6% and 17% respectively, comparing these 
results with those obtained in the other publications 
(14,16,22). 
Treatment of patients with ACC has generated much in-
terest and debate due to its slow clinical development. 
Although it is locally aggressive, with high levels of 
recurrence and late metastasis, ACC is more difficult 
to resect, which is why surgical treatment alone may 
fail in the event of recurrence in the surgical margins, 
as well as in the appearance of distant metastasis (11). 
In our series, the treatment of choice was a combina-
tion of surgery and radiotherapy in 165 of the patients, 
followed by surgery, and in smaller percentages, that 
of chemotherapy, radiotherapy or a combination of the 
three, which are results consistent with those found in 
other publications (18,21,23). However, authors such as 
Lopes et al. (24) consider surgical treatment as the usual 
therapy, limiting the combination with radiotherapy and 
chemotherapy to cases of cervical lymph node metas-
tasis and perineural invasion, as well as recurring tu-
mors.  We only found one patient who was treated with 
chemotherapy, which represented 0.4% of our sample. 
In this sense, Dood et al. (25) evaluate the efficacy of 
chemotherapy drugs in the treatment of the recurrences 
or metastases of ACC, obtaining a low response.
The existence of surgical margins free of tumors cor-
relates to a better local control and a better rate of sur-
vival, emphasizing the need to perform intraoperative 
biopsies in order to ensure the surgical margins. How-
ever, Sur et al. (26) suggest that the extension of the 
surgical resection does not affect the overall survival 
due to the slow growth of these tumors. In our series, 
48.47% of the margins were affected, such that those 
subjects with positive margins presented less rate of 
survival (4,11). Only Luna-Ortiz et al. (16) report in a 
study of 8 patients, that despite finding 6 negative mar-
gins, they obtained a low rate of survival.
 Distant metastasis of ACC can occur even decades 
after treatment of the primary tumor and after having 
achieved an adequate local-regional control, which 
means low rates of survival. In our case, a greater 
number of metastases were recorded at the local level, 
49 to 47 respectively. As for the location of the distant 
metastases, 67.35% were in the lungs, followed by 24.5% 
in the lungs and bone, a finding that coincided with the 
rest of the literature consulted (18,22,23,27).
As far as the overall survival, in our case, it was 70.76% 
at 5 years and 56.76% at 10 years. Similarly, in the study 
by Maciejewski et al. (28), in which they evaluate 47 pa-
tients with ACC, they obtained an overall survival rate 
at 5 and 10 years of 85% and 45% respectively.
Therefore, although ACC is a relatively uncommon neo-
plasm, it is a problematic pathology due to the high ten-
dency towards local recurrence and to the development 
of distant metastasis, which is why it thus requires close 
monitoring throughout the life of the patient. For this 
reason, early detection of the tumor is needed in order 
to enable early prognosis and a better quality of life for 
the patient. 
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